Skip to main content
Top
Published in:

Open Access 01-12-2025 | Acute Respiratory Distress Syndrome | Research

Using a clinical decision support system to reduce excess driving pressure: the ALARM trial

Authors: Ursula Burger-Klepp, Mathias Maleczek, Robin Ristl, Bettina Kroyer, Marcus Raudner, Claus G. Krenn, Roman Ullrich

Published in: BMC Medicine | Issue 1/2025

Login to get access

Abstract

Background

Patients at need for ventilation often are at risk of acute respiratory distress syndrome (ARDS). Although lung-protective ventilation strategies, including low driving pressure settings, are well known to improve outcomes, clinical practice often diverges from these strategies. A clinical decision support (CDS) system can improve adherence to current guidelines; moreover, the potential of a CDS to enhance adherence can possibly be further increased by combination with a nudge type intervention.

Methods

A prospective cohort trial was conducted in patients at risk of ARDS admitted to an intensive care unit (ICU). Patients were assigned to control or intervention by their date of admission: First, the control group was included without changing anything in clinical practice. Next, the CDS was activated showing an alert in the patient data management system if driving pressure exceeded recommended values; additionally, data on the performance of the wards were sent to the healthcare professionals as the nudge intervention. The main hypothesis was that this combined intervention would lead to a significant decrease in excess driving pressure.

Results

The 472 included patients (230 in the control group and 242 in the intervention group) consisted of 33% females. The median age was 64 years; median Sequential Organ Failure Assessment score was 8. There was a significant reduction in excess driving pressure in the augmented ventilation modes (0.28 ± 0.67 mbar vs. 0.14 ± 0.45 mbar, p = 0.012) but not the controlled mode (0.37 ± 0.83 mbar vs. 0.32 ± 0.8 mbar, p = 0.53). However, there was no significant difference between groups in mechanical power, the number of ventilator-free days, or the percentage of patients showing progression to ARDS. Although there was no difference in progression to ARDS, 28-day mortality was higher in the intervention group. Notably, the mean overall driving pressure across both groups was low (12.02 mbar ± 2.77).

Conclusions

In a population at risk of ARDS, a combined intervention of a clinical decision support system and a nudge intervention was shown to reduce the excessive driving pressure above 15 mbar in augmented but not in controlled modes of ventilation.
Appendix
This content is only visible if you are logged in and have the appropriate permissions.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Using a clinical decision support system to reduce excess driving pressure: the ALARM trial
Authors
Ursula Burger-Klepp
Mathias Maleczek
Robin Ristl
Bettina Kroyer
Marcus Raudner
Claus G. Krenn
Roman Ullrich
Publication date
01-12-2025
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2025
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/s12916-025-03898-2

Keynote webinar | Spotlight on innovations in retinal disease

  • Webinar | 08-07-2025 | 18:00 (CEST)

On-demand video coming soon

Retinal diseases are a significant cause of vision impairment and blindness worldwide, but the diagnostic and treatment landscape is rapidly evolving. Explore groundbreaking advances in retinal imaging and gene therapy, before taking a deep dive into emerging treatments for wet AMD.

Prof. Giuseppe Querques
Prof. Dr.med. Katarina Stingl
Dr. Miklos Schneider
Developed by: Springer Medicine
Notify me
Webinar

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest